Evid Invest
Who owns LBRXWhat LBRX owns — n/a

Who owns LB PHARMACEUTICALS INC?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of LBRX from SEC Form 13F filings across 147 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 147 institutions disclosed 34.1M shares of LB PHARMACEUTICALS INC worth $1.30B — about 103.1% of shares outstanding; the largest disclosed holder is Deep Track Capital, LP. Source: SEC Form 13F filings, parsed by EvidInvest.

147

13F holders

$1.30B

value, 2026 filers

103.1%

of shares outstanding (34.1M sh)

44

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of LBRX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Deep Track Capital, LP3.4M$128.7M2.1%10.1%0.0%
2BlackRock, Inc.2.3M$90.1M0.0%7.1%-14.2%
3RA CAPITAL MANAGEMENT, L.P.2.2M$84.8M0.9%6.7%0.0%
4Caligan Partners LP1.5M$49.6M3.0%4.6%+5.0%
5JPMORGAN CHASE & CO1.4M$53.8M0.0%4.4%-3.5%
6Spruce Street Capital LP1.4M$53.9M8.6%4.2%+2.1%
7Commodore Capital LP1.3M$49.2M3.8%3.9%-14.5%
8Trails Edge Capital Partners, LP1.1M$44.1M6.3%3.5%-24.5%
9FMR LLC1.1M$39.5M0.0%3.3%+484.4%
10VANGUARD CAPITAL MANAGEMENT LLC1.1M$42.2M0.0%3.3%+13.3%
11Nantahala Capital Management, LLC1.1M$41.2M1.3%3.2%+2.0%
12GOLDMAN SACHS GROUP INC964,373$37.0M0.0%2.9%+67.3%
13ADAGE CAPITAL PARTNERS GP, L.L.C.NEW950,343$36.5M0.1%2.9%new
14Balyasny Asset Management L.P.801,521$30.8M0.0%2.4%-13.0%
15Vivo Capital, LLC800,000$30.7M3.4%2.4%0.0%
16Alyeska Investment Group, L.P.791,592$30.4M0.1%2.4%-8.4%
17TCG Crossover Management, LLC765,050$29.4M0.8%2.3%-47.1%
18FARALLON CAPITAL MANAGEMENT, L.L.C.NEW741,410$28.5M0.1%2.2%new
19Bellevue Group AGNEW715,513$27.5M0.6%2.2%new
20STATE STREET CORP705,405$27.1M0.0%2.1%+17.2%
21Nan Fung Group Holdings Ltd630,657$24.2M16.2%1.9%0.0%
22GEODE CAPITAL MANAGEMENT, LLC624,470$24.0M0.0%1.9%+1.9%
23Janus Henderson Group Ltd.NEW581,710$22.3M0.0%1.8%new
24JENNISON ASSOCIATES LLC576,103$22.1M0.0%1.7%+6.5%
25Integral Health Asset Management, LLC470,000$18.0M1.1%1.4%+213.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month